These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 18992065)

  • 1. Double apheresis of peripheral blood stem cells in a single day in children mobilized by granulocyte colony-stimulating factor for transplantation.
    Okamoto Y; Watanabe T; Watanabe H; Onishi T; Kawano Y
    Pediatr Transplant; 2009 Jun; 13(4):440-3. PubMed ID: 18992065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
    Díaz MA; Sevilla J; de la Rubia J; Verdeguer A; Espigado I; Vicent MG; Pascual MJ; Zamora C; Arrieta R; Serrano D; del Cañizo C; Arbona C; de Arriba F; Bargay J; Brunet S; Sanz MA
    Haematologica; 2003 Aug; 88(8):919-22. PubMed ID: 12935980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
    Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M
    Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
    Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
    Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
    Körbling M; Chan KW; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
    Bone Marrow Transplant; 1996 Nov; 18(5):885-90. PubMed ID: 8932841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral blood stem cell harvest for patients with germ cell tumors].
    Okamura K; Mizutani K; Hattori R; Gotoh M; Ono Y; Ohshima S
    Hinyokika Kiyo; 2001 Jun; 47(6):397-403. PubMed ID: 11496395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF).
    Martino M; Callea I; Condemi A; Dattola A; Irrera G; Marcuccio D; Messina G; Pontari A; Pucci G; Console G; Lacopino P
    J Clin Apher; 2006 Oct; 21(3):169-75. PubMed ID: 16532489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
    Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK; Kaufman J
    Transfusion; 2007 Apr; 47(4):629-35. PubMed ID: 17381621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the economic efficacy of peripheral blood progenitor cell collections by monitoring peripheral blood CD34+ concentrations.
    Gutensohn K; Magens MM; Kuehnl P; Zeller W
    Transfusion; 2010 Mar; 50(3):656-62. PubMed ID: 20042030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors.
    Kawano Y; Takaue Y; Watanabe T; Abe T; Okamoto Y; Iwai A; Iwai T; Watanabe A; Ito E; Makimoto A; Nakagawa R; Watanabe H; Sato J; Suenaga K; Suzuya H; Ohnishi T; Kanamaru S; Kaneko M; Kuroda Y
    Cancer Res; 1999 Jul; 59(14):3321-4. PubMed ID: 10416586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
    Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
    J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients.
    Majado MJ; Minguela A; González-García C; Salido E; Blanquer M; Funes C; Insausti CL; García-Hernández AM; Moraleda JM; Morales A
    J Clin Apher; 2009; 24(1):12-7. PubMed ID: 19170164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
    Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR
    Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Fruehauf S; Klaus J; Huesing J; Veldwijk MR; Buss EC; Topaly J; Seeger T; Zeller LW; Moehler T; Ho AD; Goldschmidt H
    Bone Marrow Transplant; 2007 Jun; 39(12):743-50. PubMed ID: 17450182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.
    Basara N; Schmetzer B; Blau IW; Bischoff M; Günzelmann S; Kirsten D; Fauser AA
    Bone Marrow Transplant; 2000 Feb; 25(4):371-6. PubMed ID: 10723579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.